The combination of nivolumab and ipilimumab in patients with metastatic colorectal cancer led to 24-month progression-free survival of 72%, as compared with 14% with chemotherapy.
The New England Journal of Medicine: Search Results in Hematology/Oncology
Early-stage triple-negative breast cancers, which lack expression of three proteins (estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2), have long been defined by what they are not. Now they have found a new identity and treatment approach: they are breast cancers that benefit from immune checkpoint inhibitor…
The New England Journal of Medicine: Search Results in Hematology/Oncology
In this audio interview, Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research being presented at the 2024 European Society of Medical Oncology annual meeting. . . .
The New England Journal of Medicine: Search Results in Hematology/Oncology
Among patients with triple-negative breast cancer, 5-year survival was 86.6% with neoadjuvant pembrolizumab with chemotherapy followed by adjuvant pembrolizumab and 81.7% with neoadjuvant chemotherapy alone.
The New England Journal of Medicine: Search Results in Hematology/Oncology
Most rotator-cuff tears are degenerative, atraumatic, and more prevalent with age. Nonoperative treatment, including physical therapy, is typically recommended; surgery is considered in some cases.
The New England Journal of Medicine: Search Results in Endocrinology
In their study of a mouse model of bone loss during lactation, Babey et al. identified a hormone, secreted by brain cells, that enhances bone mass and strength.
The New England Journal of Medicine: Search Results in Endocrinology
In this cluster-randomized trial in Vietnam, a two-dose PCV10 vaccination schedule was not inferior to the routine three-dose schedule in preventing vaccine serotype carriage in infants and toddlers.
The New England Journal of Medicine: Search Results in Infectious Disease
Según una investigación reciente, las luces intermitentes de las patrullas y las ambulancias pueden provocar “ataques epilépticos digitales” en los sistemas de conducción automatizada basados en imágenes, con el consiguiente riesgo potencial de accidente.
Según una investigación reciente, las luces intermitentes de las patrullas y las ambulancias pueden provocar “ataques epilépticos digitales” en los sistemas de conducción automatizada basados en imágenes, con el consiguiente riesgo potencial de accidente. Noticias sobre negocios
Huawei abandonará por completo el uso de tecnologías provenientes de Estados Unidos con el lanzamiento de HarmonyOS Next.
Huawei abandonará por completo el uso de tecnologías provenientes de Estados Unidos con el lanzamiento de HarmonyOS Next. Noticias sobre negocios
Con su primer vehículo eléctrico, Xiaomi ya está mostrando a marcas como Ford y Volvo dónde se están equivocando y lo que Apple podría haber hecho.
Con su primer vehículo eléctrico, Xiaomi ya está mostrando a marcas como Ford y Volvo dónde se están equivocando y lo que Apple podría haber hecho. Noticias sobre negocios
